Biocitech, Romainville and Paris Santé Cochin, Paris, 23 October 2008 -- Cellectis S.A. (Alternext: ALCLS), a biotech company specialising in genome engineering, and Genomic Vision S.A., a biotech company specialising in molecular diagnosis, announce the launch of a partnership in the domain of antiviral research. This collaboration will fit into the framework of the ACTIVE project (Application CuraTive des Infections Virales par Endonucléases; the use of endonucleases to cure viral infections), with the support of the Industrial Strategic Innovation programme (ISI) of Oséo-ISI.
